Prima BioMed Ltd (Nasdaq: PBMD) announced it will receive an undisclosed clinical milestone payment from its collaboration and licensing agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE